We live in an age where everything is fast embracing technology, and very soon, even the medicine you are taking will be going digital. This is after the FDA approved Abilify, an electronic pill utilizing blockchain technology. In the most recent article on his Crunchbase profile, investment bigwig, Paul Mampilly, urges investors to buy stocks in companies such as Abilify and chip-making firms as they are about to take over the medical arena. According to Paul Mampilly, most manufacturers are now embracing the use of blockchain and bringing forth electronic pills as they pack a lot of benefits not only to them but also to the doctors and the patients taking them. This is because, these pills have digital sensors and once a patient takes them, the sensors send data to the doctor’s and also the patient’s phone, showing how the body responded to the medicine.
This makes it possible for the practitioner to determine whether the medication is working or not, thereby making it easy for him/her to decide whether the patient needs a new prescription. If the physician is forced to prescribe a new medication, then the manufacturer already has data showing where they need to improve on, to make the drugs more effective. Additionally, with such data in hand, drug makers will also be able to eliminate false claims as the data showing whether the medicine worked or not and whether it had side effects or not, will be stored safely in a blockchain. With all the benefits listed above and many others that were never brought to light, it comes as no surprise that Mampilly urges investors to buy stocks in this field, as it is clear that they will soon cash in big.
Who is Paul Mampilly?
Mampilly is an ex-Wall Street guru who now dedicates his time and money in analyzing the most viable stocks, and recommending them to investors, thereby helping them gain benefits in this ever competitive arena. Paul Mampilly has been in the finance arena all his life, a factor that explains why he is so knowledgeable when it comes to matters stocks and investing. As soon as he graduated from Fordham University with an MD in business administration, Paul Mampilly began working with some big names in Wall Street such as Bankers Trust, Kinetics asset management and many other companies, and in all he gained recognition for his prowess. He later quit wall street as he felt that he was only helping the wealthy gain more wealth and started his newsletter, Profits Unlimited, which now has over 130,000 subscribers. Through this, Paul helps average investors make profits too, through his top notch investment and stock advice. He also has other two newsletters, Extreme fortunes and True momentum, all of which have the same function as Profits unlimited.
“Our stock keeps going up,” the CEO boasted to me.https://t.co/fol0lXn5MD#Buffett #APPL #Apple #Tech #Technology #Trending #Economy #Trading #Investing #Stocks #StockMarket #ExtremeFortunes #TrueMomentum #ProfitsUnlimited #BanyanHill pic.twitter.com/vuR2LRuCBZ
— Paul Mampilly (@MampillyGuru) May 17, 2018